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A B S T R A C T
Purpose: To analyze the various types of epilepsy in subjects with chromosome 18 aberrations in order to
deﬁne epilepsy and its main clinical, electroclinical and prognostic aspects in chromosome 18 anomalies.
Methods: A careful overview of recent works concerning chromosome 18 aberrations and epilepsy has
been carried out considering the major groups of chromosomal 18 aberrations, identiﬁed using MEDLINE
and EMBASE database from 1980 to 2015.
Results: Epilepsy seems to be particularly frequent in patients with trisomy or duplication of
chromosome 18 with a prevalence of up to 65%. Approximately, over half of the patients develop epilepsy
during the ﬁrst year of life. Epilepsy can be focal or generalized; infantile spasms have also been reported.
Brain imagines showed anatomical abnormalities in 38% of patients. Some antiepileptic drugs as valproic
acid and carbamazepine were useful for treating seizures although a large majority of patients need
polytherapy.
Conclusion: Children with chromosomal 18 abnormalities can present different types of epilepsy, more
frequently focal seizures in individuals with 18q- deletion syndrome, while both complex partial
seizures and generalized tonic–clonic seizures have been described in patients who suffer for trisomy 18.
Outcome in term of seizures frequency and duration seems to be variable and epilepsy is drug resistant
in half of the children, especially in children with trisomy 18 and generalized epilepsy.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Epilepsy is among the most common neurological conditions
with a prevalence of 0.5–1% in the general population and affecting
approximately 50 million people worldwide [1,2]. Studies of
epilepsy associated with chromosomal abnormalities may provide
information about epilepsy phenotypes, such as in fragile-X,
trisomy 12p, Wolf-Hirschhorn, ring 20, and 1p36 deletion
syndromes. The mechanisms of chromosomal imbalances associ-
ated with epilepsy are of considerable neurobiological interest as
dosage imbalances might, for some neuronal genes, lay the basis
for the observed epilepsy phenotypes [3]. Trisomy 18 (Edwards
syndrome) phenotype results from full, mosaic or partial trisomy
18q [4,5]; complete or full trisomy 18 is the most common variant
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described in literature associated with seizures are: deletion
syndromes of the short (18p- deletion syndrome) and the long
(18q- deletion syndrome) arms, duplications of different tracts of
the long arm, ring chromosome 18, translocations involving
chromosome 18 and trisomy 18. However, although trisomy
18p is much rarer and less characterized than tetrasomy 18p, in
which epilepsy affects 23% of patients [6], epilepsy has also been
described in patients with trisomy 18p. Epilepsy is infrequent in
individuals with 18p- deletion syndrome, while may be part of the
clinical picture of patients with 18q- deletion syndrome [7].
Individuals with partial duplication of the long arm of chromosome
18 and ring chromosome 18 display an incomplete trisomy 18
phenotype [8,9]. The aim of the study is to describe the different
types of epilepsy and its main electroclinical and prognostic
aspects in the various chromosome 18 anomalies (Table 1).
2. Material and methods
This article provides an overview on works concerning
chromosome 18 aberrations and epilepsy, starting from 1980. Aserved.
Table 1
Clinical and electroencephalographic characteristics of epilepsy in patients with chromosome 18 aberrations.
Authors Chromosomal
aberrations
N8 of
patients/
gender
Type of seizures Onset age
of seizures
EEG ﬁndings Brain MRI ﬁndings
Novotny et al.
(1987) [33]
Trisomy 18q 1 M CPS, Myo 1 y NA Microcephaly
Johansson et al.
(1988) [35]
Trisomy 18p 1 F SPS 11 y Bilateral SLWS NA
Kanazawa et al.
(1989) [13]
18qDS 1 M GTC, SE 14 y Ictal EEGs: continuous 2 Hz high
voltage slow waves superimposed
by S and poly-spikes + irregular S
discharges in the L O regions
Immaturity of the brain
Shinzel et al.
(1991) [14]
18qDS 1 F Tonic–clonic
seizures
2 y NA NA
Vaquerizo et al.
(1995) [11]
18pDS 1 F West syndrome NA Hyp NA
Gustavsson
et al. (1999)
[15]
18qDS 1 F Unspeciﬁed type of
epilepsy
NA NA NA
Bal et al. (2000)
[24]
De novo t(2;18)
(q21;q22)
1 M Mixed type of
epilepsy
NA S, poly-spikes and SPW complexes Loss of volume of the
white matter and
delayed myelination
Sturm et al.
(2000) [16]
18qDS 1 M Autonomic seizures NA NA Multifocal
demyelination
Rao et al.
(2001) [25]
t(14;18)
(p11;q11.2), -18
1 M GTC First mo of
life
NA Hydrocephalus
Kumada et al.
(2003) [19]
18qDS 1 F CPS + autonomic
seizures
3 mo S in R P-T region Diffuse cerebral
atrophy, severe white
matter demyelination
Verrotti et al.
(2003) [17]
18qDS 1 F CPS 6 mo Low-voltage S in F-C region Normal
Adab et al.
(2005) [20]
18qDS 1 F CPS 28 y Low amplitude with diffuse fast
activity
NA
Grosso et al.
(2005) [7]
18qDS 1 F 3 M CPS 20 mo Low-medium voltage S with slow
waves, or low voltage SLWS in the
R C region in two children, in the
F-C-T region in one patient and in
the L C-T region in one child
NA
Grosso et al.
(2005) [7]
t(17;18) 1 M FS, Generalized
epilepsy
2.6 y Symmetric or asymmetric S or SPW
complexes of medium-high voltage
in the O-C-T regions
NA
Grosso et al.
(2005) [7]
Trisomy 18p 2 M CPS Mean 4.5 y Symmetric or asymmetric S and
SPW of medium-high voltage in the
O region + generalized S and
poly-spike and wave-activity
NA
Stephenson
et al. (2005)
[18]
18qDS 1 M Autonomic seizures
(epileptic apnoea)
13 mo Discharges with a wave-form with
slow theta frequency in R T region
NA
Yamanouchi
et al. (2005)
[27]
Trisomy 18 1 M Generalized
epilepsy
4 y Multifocal S in the R P and L T
regions
Cerebellar
hypogenesis + thin
corpus
callosum + dysplastic
hippocampus
Ceccarini et al.
(2007) [8]
18q21.31-q22.2
duplication
1 M GTC, FS induced by
reading
19 y Isolated short saw-tooth theta
waves sequences in F-C-T region
Enlarged cisterna
magna and cerebellar
hypoplasia (vermis and
right hemisphere)
Cerminara et al.
(2008) [12]
18pDS 1 M TS + automatisms 6 y S and SLWS in F regions often
synchronously
NA
Kumada et al.
(2010) [34]
Trisomy 18 1 F CPS + autonomic
seizures
10 mo Alfa-waves (10–12 Hz) originating
in L hemisphere for 2 seconds,
followed by high-voltage Theta-
waves and Delta-waves
Slight enlargement of
the lateral ventricles
Celep et al.
(2011) [23]
Ring
chromosome 18
1 M Febrile seizures NA Generalized epileptiform
abnormality from bilateral C P
region
MRI spectroscopy:
decreased NAA/Cr ratio
on the white matter
(F region)
Lo Castro et al.
(2011) [9]
Ring
chromosome 18
1 F FS 3 y Focal anomalies in central R region Hyperintensities in
semioval centres,
subcortical gliotic
lesions
Poulton et al.
(2011) [21]
18qDS 1 M FS, GTC, Myo 2 mo 4 mo: High voltage asymmetric
multifocal activity with progressing
into burst; 7 mo: Hyp
Simpliﬁed gyral pattern
of the cerebral cortex
and delayed
myelination, no overt
cerebellar
abnormality +
microcephaly
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Table 1 (Continued )
Authors Chromosomal
aberrations
N8 of
patients/
gender
Type of seizures Onset age
of seizures
EEG ﬁndings Brain MRI ﬁndings
D’Orsi et al.
(2012) [28]
Trisomy 18q 1 M GTC, 25 y Ictal EEGs: diffuse slow wave
complex in anterior regions
Bilateral opercular
dysplasia and corpus
callosum hypoplasia
epileptic spasms
induced by eating
Vecchio et al.
(2012) [26]
t(1;18)
(q44;p11.3)
1 M Generalized
epilepsy
13 mo Bilateral F SPW Normal
Kosho et al.
(2013) [29]
Trisomy 18 13 children GTC Mean 2 mo NA NA
Orendi et al.
(2013) [36]
Trisomy 18p 1 M Absence 4 y Focal monomorphic delta-theta
waves intermingled with high
potentials and SPW complexes in O
regions
NA
Wang et al.
(2013) [22]
18q12.1
duplication
1 F FS 5 y Normal Spinal segmentation
anomaly
(C2- C3) + focal
protrusion of the C3-C4
intervertebral
disc + mild spinal
stenosis
Kumada et al.
(2013) [32]
Trisomy 18 7 children 2 children: CPS Mean 11
mo
NA NA
4 children: GTC 1
child: unclassiﬁed
epilepsy
Del Gaudio
et al. (2014)
[30]
Trisomy 18q 1 M Mixed type of
seizures
6 y Multiple focal discharges in
posterior regions
Mild cerebral atrophy
Kobayashi et al.
(2014) [31]
Trisomy 18 1 F Generalized
epilepsy
1.5 y Background slowing and repetitive
generalized S–poly-spike and wave
discharges in bilateral F regions
Mild brain atrophy
M, male; F, female; y, years; mo, months; Hyp, hypsarrythmia; CPS, complex partial seizures; GTC, generalized tonic–clonic seizures; SE, status epilepticus; FS, focal seizures;
TLE, temporal-lobe epilepsy; SPS, simple partial seizures; Myo, myoclonic seizures; TS, tonic seizures; SPW, spike and waves; S, spike; SLWS, sharp and slow wave; R, right; L,
left; C, centro; T, temporal; O, occipital; F, frontal; P, parietal; FT, frontotemporal; NA, not available.
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to identify studies in children and adults using terms ‘‘chromosome
18’’, ‘‘chromosome 18 aberrations’’, ‘‘18p- deletion syndrome’’,
‘‘18q- deletion syndrome’’, ‘‘chromosome 18q duplications’’, ring
chromosome 1800, ‘‘translocations 18p’’, ‘‘trisomy 18’’, ‘‘epilepsy’’ and
‘‘seizures’’ as key words. Only English language articles were
reviewed. References of the selected article were consulted for
possible additional relevant articles. The date of our last search was
April 2015. In this work, we listed the major groups of chromosomal
18 aberrations and the main types of epileptic manifestations. The
following data were recorded: age, gender, chromosomal mutation,
epileptic features, MRI brain lesions and response to therapy. The
classiﬁcation of seizures was based on the clinical and EEG ﬁndings
according to criteria of International League Against Epilepsy [10].
3. Results
3.1. 18p- deletion syndrome
There are only two case reports: a Spanish child with 18p
monosomy presenting with West syndrome [11] and one patient
with a normal karyotype (46,XY) and a del(18)(p11.1pter).ish(18q-
terﬁ18p11;tel 18p-) de novo who developed intractable epilepsy
[12]. Both of them showed a multidrug-resistant epilepsy:
Vaquerizo et al. described a classical West syndrome phenotype
characterized by infantile spasms in the ﬁrst year of life and the
typical EEG pattern of hypsarrhytmia, while Cerminara et al.
reported a novel ﬁnding in a young male patient. At age 6, the boy
developed nocturnal seizures with prominent tonic and postural
manifestations, automatisms and occasional secondary generali-
zation. Sleep EEG showed spikes and sharp waves localized onfrontal leads often synchronously. Carbamazepine, oxcarbazepine,
lamotrigine, topiramate, valproic acid and clobazam were used
with poor seizure control.
3.2. 18q- deletion syndrome
There are fourteen individuals with 18q- deletion syndrome
and epilepsy. Two papers described tonic–clonic seizure as the
most common type of epilepsy in patients carrying 18q- deletion
syndrome: in 1989, Kanazawa et al. reported a 15-year-old boy
with grand mal seizures that developed status epilepticus; ictal
EEGs showed a prominent left occipital paroxysmal activity [13].
Some years later, Shinzel et al. observed in a 4-year-old male
generalized tonic–clonic seizures [14]. An unspeciﬁed type of
epilepsy was described in a 4.11-year-old female with an atypical
Rett syndrome carrying an interstitial deletion of chromosome 18q
[15]. By contrast, Sturm et al. reported an adult patient with
autonomic seizures related to the insular/temporal lobe and its
multifocal demyelination, conﬁrmed by brain MRI investigations;
the patient was treated with carbamazepine and remained seizure
free [16]. Complex partial seizures were also observed in a 3-year-
old female with benign focal epilepsy from the age of six months;
valproic acid was prescribed with complete disappearance of the
seizures after one month of therapy [17]. Therefore, in most
patients seizures appeared to be focal, occurring during the ﬁrst
years of life and well controllable. In particular, Grosso et al.
reported four patients: three boys and one girl who suffered from
complex partial seizures, with motor arrest, loss of contact, staring
gaze or ocular revulsion and autonomic symptoms. The age at
seizure onset was mean 20 months. Awake and sleep EEGs
recorded low-medium voltage spikes with or without slow waves,
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patients, in the fronto-centro-temporal area in one patient and in
the left centro-temporal area in the last one. In three patients,
seizures were quickly controlled by carbamazepine, while in one
child epilepsy control was achieved after 9 months by combination
therapy with carbamazepine and topiramate [7]. In the same year,
Stephenson et al. reported a male infant, aged 14 months, with
autonomic epilepsy (epileptic apnea), documented by appropriate
polygraphic recording (cardiac dysrhythmia simulating syncope
and blood pressure changes) and by EEG recording that showed
focal discharges with a smooth wave-form with slow theta
frequency more often from right temporal region [18]. Kumada
et al. also reported an infant having complex partial seizures with
apnoeic attacks. Ictal EEGs and 18F-ﬂuorodeoxy glucose-positron
emission tomography showed epileptic focus in the right parietal-
temporal region, while MRI revealed diffuse cerebral atrophy and
severe white matter demyelination [19]. Adab et al. reported a
29-year-old woman with chromosome 18q- deletion syndrome
who also suffered for complex partial seizures. EEG generally
showed low amplitude with excessive diffuse fast activity but no
focal epileptic discharges. Treatment with carbamazepine was
ineffective, while lamotrigine reduced the frequency of seizures
[20]. Finally, another male infant presented epilepsy at 2 months of
age: seizures were a combination of focal seizures with secondary
generalization and generalized seizures. EEG showed high voltage
asymmetric multifocal activity with abnormal background pro-
gressing into burst-suppression on sleep EEG at 4 months and
hypsarrythmia at 7 months. Brain MRI showed a simpliﬁed gyral
pattern of the cerebral cortex and delayed myelination. Epilepsy
was drug-resistant despite the treatment with clonazepam,
vigabatrin and valproic acid [21].
3.3. Chromosome 18q duplications
There are two cases reported with this chromosome abnormal-
ity: Ceccarini et al. reported three siblings carrying an interstitial
duplication of the long arm of chromosome 18 inherited from a
healthy mosaic carrier mother. The duplicated region spanned
between 18q21.31 and 18q22.2 for about 12 Mb. The ﬁrst sibling
was a 22-year-old man with ‘‘reading epilepsy’’ syndrome type
from the age of 19 years. EEG showed isolated, intercritical short
saw-tooth theta waves sequences in the fronto-centro-temporal
area bilaterally, triggered by hyperpnoea and photic stimulation
with good response to anticonvulsant therapy [8]. Some years later
a 8-year-old female was described with recurrent focal seizures,
characterized by leftward deviation of the eyes and head, blinking
and transient unresponsiveness to external stimuli, were effec-
tively treated by lamotrigine. Awake EEG was normal [22].
3.4. Ring chromosome 18
Epileptic seizures are rarely reported in patients with ring
chromosome 18: a child with febrile seizures [23] and one girl with
focal epilepsy have been described: at the age of 3 years she
presented an episode of febrile seizure and, after a few months,
partial seizures characterized by motion arrest, decreased respon-
siveness and staring of eyes. EEG showed focal paroxysmal
anomalies in the central right regions. Valproic acid was effective
with a complete disappearance of seizures [9].
3.5. Translocations chromosome 18
There are four cases reported with this chromosome abnor-
mality: three children with translocation 18q[7,24,25] and a
7-year-old male with t(1;18)(q44;p11.3) [26]. In particular,
patients carrying translocation 18q presented both partial andgeneralized epilepsies with various EEG discharges (spikes, poly-
spikes and spike-waves) in the posterior regions. Among these
children, only one was effectively treated by valproic acid and
topiramate [7]. Finally, the patient with translocation 18p
presented generalized epilepsy; EEG showed spike-wave dis-
charges and multiple spike discharges in both frontal derivations.
Polytherapy (phenobarbital, valproic acid and lamotrigine) was
required to reduce seizure frequency with poor results [26].
3.6. Trisomy 18
Seizures and central apnoea are described in 25–50% of the
children [5], even if the electroclinical aspects are not well deﬁned;
in fact, both complex partial seizures and generalized tonic–clonic
seizures have been described. Nine patients presented generalized
tonic–clonic seizures [27–32]. In two of them generalized seizures
were preceded, respectively, by spasms and tonic asymmetric
seizures until the age of 12 years [30] or by reﬂex periodic spasms
triggered by eating until the age of 25 years [28]. In all patients,
different antiepileptic drugs (AEDs) were used (phenobarbital,
valproic acid and ruﬁnamide) but seizure control was poor. Six
patients, instead, presented complex partial seizures characterized
by loss of consciousness, eye deviation towards the right or the left
side, with or without deviation of the head [7,32–35]. One of them
also presented cyanosis and apnoeic episodes (autonomic sei-
zures) [34], while another patient also suffered from myoclonic
seizures [33]. EEG showed medium-high voltage waves. All these
patients achieved a good control of seizures respectively with
valproic acid and clonazepam, and zonisamide. Furthermore,
Johansson et al. described a 12-year-old female with simple partial
epileptic seizures that started when she was 11 years old and
bilateral sharp-waves were found on EEG; seizures disappeared
with carbamazepine treatment [35]. Four patients also presented
epileptic spasms [31,32]. In particular, Kobayashi et al. reported a
female who used valproic acid without obtaining seizure-control:
EEG showed generalized bilateral spikes/polyspikes and waves
without typical hypsarrhytmia and focal hyperexcitability with
monomorphic delta-theta waves intermingled with high poten-
tials and spike-wave complexes in the occipital areas [31].
Moreover, absence epilepsy occurred, between 4 and 8 years of
age, in a patient who was successfully treated with lamotrigine
[36].
On the whole, the most frequent seizures reported in Trisomy
18 patients are tonic–clonic and partial complex seizures. AEDs
did not prove to be effective in most patients with generalized
tonic–clonic seizures whereas all patients with partial complex
seizures achieved a good seizure control through AEDs therapy
(in particular with valproic acid and clonazepam, and with
zonisamide).
4. Discussion
A detailed analysis of the electroclinical pattern of epilepsy
associated with chromosomal disorders can help to deﬁne the
phenotype and to detect genes related to seizure susceptibility [1].
Over 500 different chromosomal imbalances have been described
with seizures or EEG abnormalities. Some chromosomal disorders
had a high association with epilepsy, e.g., Wolf-Hirschhorn (4p-),
Miller-Dieker (del 17p13.3), Angelman syndrome (del 15q11-q13),
inversion duplication 15, and ring chromosomes 14 and 20. Many
other segments had a weaker association with seizures. Less than
50 patients with rearrangements involving chromosome 18 are
available in literature but the incomplete description of the
epilepsy in many reports makes it often difﬁcult to identify precise
genotype–phenotype correlations. However, epilepsy seems to be
particularly frequent in patients with trisomy or duplication of
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half of the patients develop epilepsy during infancy or early
childhood. Epilepsy can be focal or generalized and some patients
with epileptic encephalopathy, namely, infantile spasms, have also
been reported. Outcome in terms of seizures frequency and
duration is variable and seizures may be drug-resistant in half of
the children, especially in those presenting with generalized
epilepsy. In this re-evaluation of the literature only two children
were described with 18p- deletion syndrome and epilepsy:
seizures are infrequent in individuals with this type of anomaly
and epilepsy seems to be characterized by poor seizure control. We
also found fourteen patients with 18q- deletion syndrome who
suffered from epilepsy: in most cases, seizures appear to be focal,
mainly occurring during the ﬁrst years of life and well controllable.
In addition, ten individuals were observed with epilepsy and
chromosome 18q duplications in four cases, ring chromosome 18
in other two children and translocations 18p in four patients: these
chromosome anomalies are associated with both partial and
generalized epilepsies and prognosis is variable. In patients with
translocation involving the long arm of chromosome 18, it is not
possible to establish whether epilepsy depends on chromosome 18
anomalies or on the other chromosomes involved in the
rearrangement. The association between epilepsy and Edwards
syndrome lacks detailed descriptions and this is probably due to
the high mortality of these patients in the ﬁrst year of life [30].
Even if the descriptions are rare, epilepsy in partial trisomy 18 (18p
and 18q) seems to have a common clinical and electroencephalo-
graphic pattern being characterized by late onset epilepsy with
generalized and focal seizures (18q) or only focal (18p) and an EEG
pattern with generalized and focal discharges mainly over the
posterior regions. Overall, outcome in terms of seizures frequency
and duration can vary with better prognosis in 18p than 18q
trisomy [7,28]. More data are available for full trisomy 18: epilepsy
appears to be characterized by the occurrence of both focal and
generalized seizures and an EEG showing focal and generalized
discharges, onset is usually during infancy, commonly in the ﬁrst
year of life; an infant with trisomy 18 developed epileptic apnea
similar to central apnea: no epileptic discharges were detected in
any interictal EEGs, while ictal EEG and the [18F] ﬂuorodeox-
yglucose-positron emission tomography ﬁndings conﬁrmed that
the apneic episodes were complex partial seizures, probably
originating in the left fronto-temporal area. Epileptogenic foci in
apneic seizures were most commonly located in the temporal lobe
and less commonly in the frontal and parietal lobes. Differentiation
of epileptic apnea from central apnea is crucial: a misdiagnosis can
be harmful to infants with epileptic apnea. Outcome is very
variable: some patients may respond well to one AED, while others
can be resistant to all therapies. In particular, patients with focal
epilepsy with complex partial seizures showed a good prognosis of
the epilepsy, while in generalized epilepsy, characterized by
spasms or tonic seizures as common phenotypes, seizures were
markedly intractable [34]. The reason why patients with trisomy
18 develop epilepsy at high frequency is still unknown. It is
possible that the different phenotype of these conditions (18q, 18p
and full trisomy 18) reﬂects the different gene content of the
aberration [30]. However, genotype–phenotype correlations are
quite difﬁcult as most rearrangements, although cytogenetically
short, encompass dozens if not hundreds of genes. However, the
mechanisms of the enlarging number of chromosomal imbalances
associated with epilepsy are of considerable neurobiological
interest. These dosage imbalances might, for some neuronal genes,
lay the basis for the observed epilepsy phenotypes. Among these,
some genes are of special interest as they could be implicated in
epilepsy pathogenesis: SYP4 that encodes synaptogamin 4, a
protein with a crucial role in synaptic transmission [37]; IER3IP1,
which codiﬁes immediate early response 3 interacting protein 1and is mutated in patients with myoclonic epilepsy [21]; MBD1
and MBD2, that codify methyl-CpG binding domain protein 1 and
2, nuclear proteins with a methyl-CpG binding domain [38]; TCF4
which encodes a protein called transcription factor 4 involved in
the pathogenesis of Pitt–Hopkins Syndrome, an encephalopathy
characterized by severe epilepsy[39]; NEDD4L, that codiﬁes a
member of the Nedd4 family of HECT domain E3 ubiquitin ligases
implicated in the origin of a epileptic encephalopathy [40]. It is
difﬁcult to state which of these genes plays a major role in the
pathophysiology of epilepsy associated with chromosome 18
rearrangements. The associated phenotypes, may reﬂect a
‘‘general’’ effect in which neuronal development, migration,
differentiation and functioning have progressed less than optimal-
ly, because of haploinsufﬁciency or excess of a collection of genes,
resulting in fairly nonspeciﬁc neurologic abnormalities, including a
lowered seizure threshold. It is also possible that the overall
burden of the rearranged products and their interactions lead to
the disease. Although the function of the proteins encoded by these
genes make them promising candidate genes for the pathophysi-
ology of epilepsy in this condition, functional studies are needed to
clarify their exact role.
5. Conclusions
Among chromosome 18 abnormalities, 18q- deletion syndrome
and full trisomy 18 are frequently associated with epilepsy. In most
patients with 18q- deletion syndrome, seizures are focal, occurring
during the ﬁrst years of life with fair response to valproic acid or
carbamazepine, while trisomy 18 is associated with both partial
and generalized epilepsies with onset in the ﬁrst year of life and a
variable prognosis. The treatment of epilepsy in children with 18
chromosome abnormalities should be prompt and aggressive with
adequate doses of effective medications in order to reduce the risk
of prolonged seizures. The large majority of AEDs is not effective in
patients with generalized seizures whereas many patients with
partial complex seizure achieve a good seizure control through
AEDs therapy; the most used AEDs are valproic acid or lamotrigine
monotherapy; when polytherapy is required, the most useful
association could be carbamazepine and topiramate, valproic acid
and topiramate, or valproic acid and clonazepam.
The identiﬁcation of additional patients with epilepsy and
chromosome 18 rearrangements will better clarify whether this
chromosomal abnormality is associated with a speciﬁc epileptic
syndrome and the eventual role of speciﬁc genes in determining
the phenotype of these patients.
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